Anhui Heryi Pharmaceutical Co (BJSE:430478) 3-Year EBITDA Growth Rate : -7.90% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Heryi Pharmaceutical Co 3-Year EBITDA Growth Rate?

Anhui Heryi Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.32.

During the past 12 months, Anhui Heryi Pharmaceutical Co's average EBITDA Per Share Growth Rate was -32.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -7.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Anhui Heryi Pharmaceutical Co was 26.80% per year. The lowest was -32.30% per year. And the median was 13.55% per year.

Competitive Comparison of Anhui Heryi Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Anhui Heryi Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anhui Heryi Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anhui Heryi Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Anhui Heryi Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Anhui Heryi Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Anhui Heryi Pharmaceutical Co (BJSE:430478) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Anhui Heryi Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Anhui Heryi Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Heryi Pharmaceutical Co (BJSE:430478) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Heryi Pharmaceutical Co Ltd (BJSE:430478) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Yangcun Industrial Zone, Anhui Province, Tianchang City, CHN, 239304

Website

http://www.heryipharma.com

Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of advanced pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.

Anhui Heryi Pharmaceutical Co (BJSE:430478) Headlines

No Headlines